russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2022-5243russjcardiol-5243Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWОсобенности протокола трансторакального эхокардиографического исследования у пациентов с ожирениемAspects of transthoracic echocardiography protocol in obese patientshttps://orcid.org/0000-0002-5384-3795ДжиоеваО. Н.DzhioevaO. N.

Ольга Николаевна Джиоева — доктор медицинских наук, ведущий научный сотрудник отдела фундаментальных и прикладных аспектов ожирения, руководитель лаборатории кардиовизуализации, вегетативной регуляции и сомнологии, профессор кафедры терапии и профилактической медицины.

Москва

Moscow

dzhioevaon@gmail.comhttps://orcid.org/0000-0003-4947-8139МаксимоваО. А.MaksimovaO. A.

Ольга Александровна Максимова — лаборант-исследователь отдела фундаментальных и прикладных аспектов ожирения.

Москва

Moscow

olya8kosenko@gmail.comhttps://orcid.org/0000-0001-8993-7892РогожкинаЕ. А.RogozhkinaE. A.

Елизавета Александровна Рогожкина — лаборант-исследователь отдела фундаментальных и прикладных аспектов ожирения.

Москва

Moscow

olya8kosenko@gmail.comhttps://orcid.org/0000-0002-4453-8430ДрапкинаО. М.DrapkinaO. M.

Оксана Михайловна Драпкина — академик РАН, доктор медицинских наук, профессор, директор, заведующий кафедрой терапии и профилактической медицины.

Москва

Moscow

drapkina@bk.ruФГБУ Национальный медицинский исследовательский центр терапии и про филактической медицины, Минздрав России; ФГБОУ ВО Московский государственный медико-стоматологический университет им. А.И. Евдокимова Минздрава РоссииРоссияNational Medical Research Center for Therapy and Preventive Medicine; A.I. Evdokimov Moscow State University of Medicine and DentistryRussian FederationФГБУ Национальный медицинский исследовательский центр терапии и про филактической медицины, Минздрав РоссииРоссияNational Medical Research Center for Therapy and Preventive MedicineRussian Federation202204012023271252435243Copyright © Джиоева О.Н., Максимова О.А., Рогожкина Е.А., Драпкина О.М., 20232023Джиоева О.Н., Максимова О.А., Рогожкина Е.А., Драпкина О.М.Dzhioeva O.N., Maksimova O.A., Rogozhkina E.A., Drapkina O.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/5243

Нередко при обследовании больных с ожирением и проведении им трансторакального эхокардиографического исследования наблюдаются нормальные показатели внутрисердечной гемодинамики и геометрии сердца. Может ли врач, анализирующий результаты исследования, определить риск сердечнососудистых осложнений и тактику ведения у таких пациентов на основании полученных данных? Действительно ли у многих пациентов с избыточной массой тела нет изменений в работе сердца или их просто не смогли выявить? С помощью новых возможностей трансторакальной эхокардиографии появляется гораздо больше способов выявить нарушения на ранних стадиях заболевания, даже при отсутствии клинических проявлений. Таким образом, включение в стандартный протокол эхокардиографии у больных с ожирением дополнительных параметров позволит наиболее точно определить тактику ведения и прогноз, тем самым снизить риск неблагоприятных исходов.

Often, transthoracic echocardiography in obese patients reveals normal indicators of intracardiac hemodynamics and heart geometry. Can the clinician determine the risk of cardiovascular events and proper management in such patients based on the data obtained? Do many overweight patients really have no cardiac abnormalities, or they simply could not be detected? New capabilities of transthoracic echocardiography make it possible to detect abnormalities in the early stages of the disease, even in the absence of clinical manifestations. Thus, the inclusion of additional parameters in the standard protocol of echocardiography in obese patients will most accurately determine the management tactics and prognosis, thereby reducing the risk of unfavorable outcomes.

эхокардиографияглобальная продольная деформацияремоделированиеэпикардиальная жировая тканьвисцеральное ожирениеechocardiographyglobal longitudinal strainremodelingepicardial adipose tissuevisceral obesityReferencesЗадорожная М. П., Разумов В. В. Спорные вопросы эхокардиографического определения массы миокарда левого желудочка и его гипертрофии (аналитический обзор и собственные наблюдения). Современные проблемы науки и образования. 2015;(6):216.EDNVJPSSN.Zadorozhnaya MP, Razumov VV. Controversial issues of echocardiographic determi nation of the mass of the left ventricular myocardium and hypertrophy (analytical review and own observations). Modern Problems of Science and Education. 2015;(6):216. (In Russ.)Карев Е. А., Вербило С. Л., Малев Э. Г. и др. Количественная ультразвуковая оценка показателей деформации миокарда: от теории к практике. Трансляционная медицина. 2020;7(6):16-28. doi:10.18705/2311-4495-2020-7-6-16-28.Karev EA, Verbilo SL, Malev EG, et al. Myocardial strain echocardiographic assessment: from theory to practice. Translational Medicine. 2020;7(6):16-28. (In Russ.) doi:10.18705/2311-4495-2020-7-6-16-28.Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. doi:10.1016/j.echo.2014.10.003.Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. doi:10.1016/j.echo.2014.10.003.Voigt JU, Pedrizzetti G, Lysyansky P, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J Am Soc Echocardiogr. 2015;28(2):18393. doi:10.1016/j.echo.2014.11.003.Voigt JU, Pedrizzetti G, Lysyansky P, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J Am Soc Echocardiogr. 2015;28(2):18393. doi:10.1016/j.echo.2014.11.003.Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. doi:10.1093/eurheartj/ehw128.Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. doi:10.1093/eurheartj/ehw128.Lewis A, Rayner JJ, Abdesselam I, et al. Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy. Int J Cardiovasc Imaging, 2021;37(7):2277-81. doi:10.1007/s10554-021-02207-1.Lewis A, Rayner JJ, Abdesselam I, et al. Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy. Int J Cardiovasc Imaging, 2021;37(7):2277-81. doi:10.1007/s10554-021-02207-1.Chirinos JA, Rietzschel ER, De Buyzere ML, et al. Arterial load and ventricular-arterial coupling: physiologic relations with body size and effect of obesity. Hypertension. 2009;54(3):558-66. doi:10.1161/HYPERTENSIONAHA.109.131870.Chirinos JA, Rietzschel ER, De Buyzere ML, et al. Arterial load and ventricular-arterial coupling: physiologic relations with body size and effect of obesity. Hypertension. 2009;54(3):558-66. doi:10.1161/HYPERTENSIONAHA.109.131870.Chirinos JA, Sardana M, Satija V, et al. Effect of Obesity on Left Atrial Strain in Persons Aged 35-55 Years (The Asklepios Study). Am J Cardiol. 2019;123(5):854-61. doi:10.1016/j.amjcard.2018.11.035.Chirinos JA, Sardana M, Satija V, et al. Effect of Obesity on Left Atrial Strain in Persons Aged 35-55 Years (The Asklepios Study). Am J Cardiol. 2019;123(5):854-61. doi:10.1016/j.amjcard.2018.11.035.Reddy YNV, Carter RE, Obokata M, et al. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018;138(9):861-70. doi:10.1161/CIRCULATIONAHA.118.034646.Reddy YNV, Carter RE, Obokata M, et al. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018;138(9):861-70. doi:10.1161/CIRCULATIONAHA.118.034646.Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-63. doi:10.1016/j.echo.2005.10.005.Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-63. doi:10.1016/j.echo.2005.10.005.Abduch MC, Alencar AM, Mathias W Jr, Vieira ML. Cardiac mechanics evaluated by speckle tracking echocardiography. Arq Bras Cardiol. 2014;102(4):403-12. doi:10.5935/abc.20140041.Abduch MC, Alencar AM, Mathias W Jr, Vieira ML. Cardiac mechanics evaluated by speckle tracking echocardiography. Arq Bras Cardiol. 2014;102(4):403-12. doi:10.5935/abc.20140041.Никифоров В. С., Никищенкова Ю. В. Cовременные возможности speckle tracking эхокардиографиии в клинической практике. Рациональная Фармакотерапия в Кардиологии. 2017;13(2):248-55. doi:10.20996/1819-6446-2017-13-2-248-255.Nikiforov VS, Nikishchenkova IV. Modern Possibilities of Speckle Tracking Echocardiography in Clinical Practice. Rational Pharmacotherapy in Cardiology 2017;13(2):248-55. (In Russ.) doi:10.20996/1819-6446-2017-13-2-248-255.Бусленко Н. С., Бузиашвили Ю. И., Кокшенева И. В. и др. Ремоделирование правых отделов сердца у больных ишемической болезнью сердца: клинико-патофизиологические корреляции. Кардиоваскулярная терапия и профилактика. 2005;4(5):23-31. EDN ISWOLV.Buslenko NS, Buziashvili YuI, Koksheneva IV, et al. Right heart remodeling in coronary heat disease: clinico-pathophysiological correlations. Cardiovascular Therapy and Prevention. 2005;4(5):23-31. (In Russ.)Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347-55. doi:10.1079/bjn20041213.Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347-55. doi:10.1079/bjn20041213.Vieira MJ, Teixeira R, Gonçalves L, Gersh BJ. Left atrial mechanics: echocardiographic assessment and clinical implications. J Am Soc Echocardiogr. 2014;27(5):463-78. doi:10.1016/j.echo.2014.01.021.Vieira MJ, Teixeira R, Gonçalves L, Gersh BJ. Left atrial mechanics: echocardiographic assessment and clinical implications. J Am Soc Echocardiogr. 2014;27(5):463-78. doi:10.1016/j.echo.2014.01.021.Митрошина Е. В. Состояние сердца по данным эхокардиографии у лиц с ожирением, манифестировавшим в пубертатный период. Ожирение и метаболизм. 2011;8(3):3845. doi:10.14341/2071-8713-4835.Mitroshina EV. The state of the heart according to echocardiography in obese individuals who manifested during puberty Obesity and metabolism. 2011;8(3):38-45. (In Russ.) doi:10.14341/2071-8713-4835.Wang L, Zhao LP, Chen Y, et al. Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction. Adipositasparadox bei pulmonaler Hypertonie aufgrund linksventrikulärer systolischer Dysfunktion. Herz. 2021;46(6):575-80. doi:10.1007/s00059-021-05023-4.Wang L, Zhao LP, Chen Y, et al. Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction. Adipositasparadox bei pulmonaler Hypertonie aufgrund linksventrikulärer systolischer Dysfunktion. Herz. 2021;46(6):575-80. doi:10.1007/s00059-021-05023-4.Cohen LP, Vittinghoff E, Pletcher MJ, et al. Association of Midlife Cardiovascular Risk Factors With the Risk of Heart Failure Subtypes Later in Life. J Card Fail. 2021;27(4):43544. doi:10.1016/j.cardfail.2020.11.008.Cohen LP, Vittinghoff E, Pletcher MJ, et al. Association of Midlife Cardiovascular Risk Factors With the Risk of Heart Failure Subtypes Later in Life. J Card Fail. 2021;27(4):43544. doi:10.1016/j.cardfail.2020.11.008.Di Salvo G, Pacileo G, Del Giudice EM, et al. Abnormal myocardial deformation properties in obese, non-hypertensive children: an ambulatory blood pressure monitoring, standard echocardiographic, and strain rate imaging study. European heart journal. 2006;27(22):2689-95. doi:10.1093/eurheartj/ehl163.Di Salvo G, Pacileo G, Del Giudice EM, et al. Abnormal myocardial deformation properties in obese, non-hypertensive children: an ambulatory blood pressure monitoring, standard echocardiographic, and strain rate imaging study. European heart journal. 2006;27(22):2689-95. doi:10.1093/eurheartj/ehl163.El Saiedi SA, Mira MF, Sharaf SA, et al. Left ventricular diastolic dysfunction without left ventricular hypertrophy in obese children and adolescents: a Tissue Doppler Imaging and Cardiac Troponin I Study. Cardiol Young. 2018;28(1):76-84. doi:10.1017/S1047951117001627.El Saiedi SA, Mira MF, Sharaf SA, et al. Left ventricular diastolic dysfunction without left ventricular hypertrophy in obese children and adolescents: a Tissue Doppler Imaging and Cardiac Troponin I Study. Cardiol Young. 2018;28(1):76-84. doi:10.1017/S1047951117001627.Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39-48. doi:10.1161/CIRCULATIONAHA.106.675355.Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39-48. doi:10.1161/CIRCULATIONAHA.106.675355.Nakanishi K, Fukuda S, Tanaka A, et al. Relationships Between Periventricular Epi car dial Adipose Tissue Accumulation, Coronary Microcirculation, and Left Ventricular Diastolic Dysfunction. Can J Cardiol. 2017;33(11):1489-97. doi:10.1016/j.cjca.2017.08.001.Nakanishi K, Fukuda S, Tanaka A, et al. Relationships Between Periventricular Epi car dial Adipose Tissue Accumulation, Coronary Microcirculation, and Left Ventricular Diastolic Dysfunction. Can J Cardiol. 2017;33(11):1489-97. doi:10.1016/j.cjca.2017.08.001.Kossaify A, Nicolas N. Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography. Clin Med Insights Cardiol. 2013;7:43-50. doi:10.4137/CMC.S11156.Kossaify A, Nicolas N. Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography. Clin Med Insights Cardiol. 2013;7:43-50. doi:10.4137/CMC.S11156.Negi SI, Jeong EM, Shukrullah I, et al. Association of low plasma adiponectin with early diastolic dysfunction. Congest Heart Fail. 2012;18(4):187-91. doi:10.1111/j.1751-7133.2011.00276.x.Negi SI, Jeong EM, Shukrullah I, et al. Association of low plasma adiponectin with early diastolic dysfunction. Congest Heart Fail. 2012;18(4):187-91. doi:10.1111/j.1751-7133.2011.00276.x.Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol. 2008;51(1):1-11. doi:10.1016/j.jacc.2007.09.026.Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol. 2008;51(1):1-11. doi:10.1016/j.jacc.2007.09.026.Bailey GW, Braniff BA, Hancock EW, Cohn KE. Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med. 1968;69(1):13-20. doi:10.7326/00034819-69-1-13.Bailey GW, Braniff BA, Hancock EW, Cohn KE. Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med. 1968;69(1):13-20. doi:10.7326/00034819-69-1-13.Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation. 1976;53(2):273-9. doi:10. 1161/01.cir.53.2.273.Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation. 1976;53(2):273-9. doi:10. 1161/01.cir.53.2.273.Ионин В. А., Заславская Е. Л., Бараш кова Е. И. и др. Предикторы рецидива фибрилляции предсердий у пациентов с метаболическим синдромом после радиочастотной изоляции устьев легочных вен. Российский кардиологический журнал. 2022;27(3S):5184. doi:10.15829/1560-4071-20225184.EDNBPOIFI.Ionin VA, Zaslavskaya EL, Barashkova EI, et al. Predictors of atrial fibrillation recur rence in patients with metabolic syndrome after pulmonary vein isolation. Russian Journal of Cardiology. 2022;27(3S):5184. (In Russ.) doi:10.15829/1560-4071-20225184.EDNBPOIFI.Чумакова Г. А., Гриценко О. В., Груздева О. В., Затеев А. В. Прогнозирование риска развития диастолической дисфункции левого желудочка при ожирении. Российский кардиологический журнал. 2022;27(4):4811. doi:10.15829/1560-40712022-4811.EDNATRJCZ.Chumakova GA, Gritsenko OV, Gruzdeva OV, Zateev AV. Predicting the risk of left ventricular diastolic dysfunction in obesity. Russian Journal of Cardiology. 2022;27(4):4811. (In Russ.) doi:10.15829/1560-40712022-4811.EDNATRJCZ.Дружилов М. А., Кузнецова Т. Ю. Эпикардиальное висцеральное ожирение как предиктор тяжести течения COVID-19 у пациентов с избыточным весом и ожирением. Российский кардиологический журнал. 2022;27(3):4850. doi:10.15829/15604071-2022-4850.Druzhilov MA, Kuznetsova TYu. Epicardial adiposity as a predictor of COVID-19 severity in overweight and obese patients. Russian Journal of Cardiology. 2022;27(3):4850. (In Russ.) doi:10.15829/15604071-2022-4850.Le Jemtel TH, Samson R, Ayinapudi K, et al. Epicardial Adipose Tissue and Cardiovascular Disease. Current hypertension reports. 2019;21(5):36. doi:10.1007/s11906-019-0939-6.Le Jemtel TH, Samson R, Ayinapudi K, et al. Epicardial Adipose Tissue and Cardiovascular Disease. Current hypertension reports. 2019;21(5):36. doi:10.1007/s11906-019-0939-6.Чумакова Г. А., Веселовская Н. Г. Методы оценки висцерального ожирения в клинической практике. Российский кардиологический журнал. 2016;(4):89-96. doi:10.15829/1560-40712016-4-89-96.Chumakova GA, Veselovskaya NG. Methods of visceral obesity assessment in clinical practice. Russian Journal of Cardiology. 2016;(4):89-96. (In Russ.) doi:10.15829/1560-40712016-4-89-96.Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471-7. doi:10.1001/jama.292.20.2471.Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471-7. doi:10.1001/jama.292.20.2471.Ansaldo AM, Montecucco F, Sahebkar A, et al. Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol. 2019;278:254-60. doi:10.1016/j.ijcard.2018.09.089.Ansaldo AM, Montecucco F, Sahebkar A, et al. Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol. 2019;278:254-60. doi:10.1016/j.ijcard.2018.09.089.Pugliese NR, Paneni F, Mazzola M, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail. 2021;23(11):1858-71. doi:10.1002/ejhf.2337.Pugliese NR, Paneni F, Mazzola M, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail. 2021;23(11):1858-71. doi:10.1002/ejhf.2337.Hendricks S, Dykun I, Balcer B, et al. Epicardial adipose tissue is a robust measure of increased risk of myocardial infarction — a meta-analysis on over 6600 patients and rationale for the EPIC-ACS study. Medicine (Baltimore). 2021;100(52):e28060. doi:10.1097/MD.0000000000028060.Hendricks S, Dykun I, Balcer B, et al. Epicardial adipose tissue is a robust measure of increased risk of myocardial infarction — a meta-analysis on over 6600 patients and rationale for the EPIC-ACS study. Medicine (Baltimore). 2021;100(52):e28060. doi:10.1097/MD.0000000000028060.Fisser C, Colling S, Debl K, et al. The impact of epicardial adipose tissue in patients with acute myocardial infarction. Clin Res Cardiol. 2021;110(10):1637-46. doi:10.1007/s00392-021-01865-4.Fisser C, Colling S, Debl K, et al. The impact of epicardial adipose tissue in patients with acute myocardial infarction. Clin Res Cardiol. 2021;110(10):1637-46. doi:10.1007/s00392-021-01865-4.Jung ED, Chung DS, Lee JY. The Correlation Between Visceral Fat Distance Measured by Ultrasonography and Visceral Fat Amount by Computed Tomography in Type 2 Diabetes. Korean Diabetes J. 2008;32(5):418-27. doi:10.4093/kdj.2008.32.5.418.Jung ED, Chung DS, Lee JY. The Correlation Between Visceral Fat Distance Measured by Ultrasonography and Visceral Fat Amount by Computed Tomography in Type 2 Diabetes. Korean Diabetes J. 2008;32(5):418-27. doi:10.4093/kdj.2008.32.5.418.Pimanov S, Bondarenko V, Makarenko E. Visceral fat in different locations assessed by ultrasound: Correlation with computed tomography and cut-off values in patients with metabolic syndrome. Clin Obes. 2020;10(6):e12404. doi:10.1111/cob.12404.Pimanov S, Bondarenko V, Makarenko E. Visceral fat in different locations assessed by ultrasound: Correlation with computed tomography and cut-off values in patients with metabolic syndrome. Clin Obes. 2020;10(6):e12404. doi:10.1111/cob.12404.Mauad FM, Chagas-Neto FA, Benedeti ACGS, et al. Reproducibility of abdominal fat assessment by ultrasound and computed tomography. Radiol Bras. 2017;50(3):141-7. doi:10.1590/0100-3984.2016.0023.Mauad FM, Chagas-Neto FA, Benedeti ACGS, et al. Reproducibility of abdominal fat assessment by ultrasound and computed tomography. Radiol Bras. 2017;50(3):141-7. doi:10.1590/0100-3984.2016.0023.Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715-25. doi:10.1016/S2213-8587(19)30084-1.Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715-25. doi:10.1016/S2213-8587(19)30084-1.Abergel E, Tase M, Bohlender J, et al. Which definition for echocardiographic left ventri cular hypertrophy? Am J Cardiol. 1995;75(7):498-502. doi:10.1016/s0002-9149(99)80589-x.Abergel E, Tase M, Bohlender J, et al. Which definition for echocardiographic left ventri cular hypertrophy? Am J Cardiol. 1995;75(7):498-502. doi:10.1016/s0002-9149(99)80589-x.Sugimoto T, Dulgheru R, Bernard A, et al. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2017;18(8):833-40. doi:10.1093/ehjci/jex140.Sugimoto T, Dulgheru R, Bernard A, et al. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2017;18(8):833-40. doi:10.1093/ehjci/jex140.Pathan F, D’Elia N, Nolan MT, et al. Normal Ranges of Left Atrial Strain by SpeckleTracking Echocardiography: A Systematic Review and Meta-Analysis. J Am Soc Echocardiogr. 2017;30(1):59-70.e8. doi:10.1016/j.echo.2016.09.007.Pathan F, D’Elia N, Nolan MT, et al. Normal Ranges of Left Atrial Strain by SpeckleTracking Echocardiography: A Systematic Review and Meta-Analysis. J Am Soc Echocardiogr. 2017;30(1):59-70.e8. doi:10.1016/j.echo.2016.09.007.

The authors declare that there are no conflicts of interest present.